On October 22, 2026, the U.S. Treasury Department proposed updated rules for implementing the Comprehensive Outbound Investment National Security (COINS) Act of 2025 to restrict U.S. investment in the Chinese biotechnology sector

From the articleTrump administration proposes new curbs on China biotech dealsAlso in Treasury proposal would sharply limit US investments in much of China biotech, Did the US just kill off China biotech deals? Live at 11:30 am ET, US Proposes Curbs on Investment in Chinese Biotech Firms, Treasury proposes major restrictions to U.S. investment in Chinese biotech sector